DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 58 · 1987 DOI: 10.1055/s-009-45132

Review Article

801
Hanson, Stephen R; Harker, Laurence A: Baboon Models of Acute Arterial Thrombosis

Original Article

806
Thompson, E Anne; Salem, Hatem H: The Effects of Human Thrombomodulin on the Inactivation of Thrombin by Its Serum Inhibitors
811
Wessels, P; Heyns, A du P; Esterhuysen, A J; Badenhorst, P N; Lötter, M G; Pieters, H; Kotzè, H F: Kinetics and In Vivo Distribution of In-111-Labelled Platelets and Platelet Function in Familial Hypercholesterolaemia
817
Gram, Jørgen; Kluft, Cornelis; Jespersen, Jørgen: Depression of Tissue Plasminogen Activator (t-PA) Activity and Rise of t-PA Inhibition and Acute Phase Reactants in Blood of Patients with Acute Myocardial Infarction (AMI)
822
Larsson, G; Larsson, Å; Åstedt, B: Tissue Plasminogen Activator and Urokinase in Normal, Dysplastic and Cancerous Squamous Epithelium of the Uterine Cervix
827
Korbut, R; Dembińska-Kieć, A; Świȩs, J; Źmuda, A; Gryglewski, R J: On the Mechanism of Thrombolytic Action of Thromboxane Synthetase Inhibitors
831
Christensen, S Winter; Wille-Jørgensen, P; Kjær, L; Stadeager, C; Widding, A; Vestergaard, Aa; Bjerg-Nielsen, A: Contact Thermography, 99mTc-Plasmin Scintimetry and 99mTc-Plasmin Scintigraphy as Screening Methods for Deep Venous Thrombosis Following Major Hip Surgery
834
Lande, Knut; Kjeldsen, Sverre Erik; Eide, Ivar; Leren, Paul; Gjesdal, Knut: Does Increased Platelet Release Normalize During Anti-Hypertensive Treatment?
839
Merton, R E; Thomas, D P: Experimental Studies on the Relative Efficacy of Dermatan Sulphate and Heparin as Antithrombotic Agents
843
Anglés-Cano, E; Boutière, B; Arnoux, D; Masson, C; Contant, G; Benchimol, P; Sampol, J: Release Pattern of the Vascular Plasminogen Activator and Its Inbibitor in Human Postvenous Occlusion Plasma as Assessed by a Spectrophotometric Solid-Phase Fibrin-tPA Activity Assay
850
McCrohan, M B; Huang, S W; Sleasman, J W; Klein, P A; Kao, K J: Plasma Thrombospondin as an Indicator of Intravascular Platelet Activation in Patients with Vasculitis
853
Fey, Martin F; Lang, Mathis; Furlan, Miha; Beck, Eugen A: Monitoring of Heparin Therapy with the Activated Partial Thromboplastin Time and Chromogenic Substrate Assays
856
Dati, F; Barthels, M; Conard, J; Flückiger, J; Girolami, A; Hänseler, E; Huber, J; Keller, F; Kolde, H -J; Müller-Berghaus, G; Samama, M; Thiel, W: Multicenter Evaluation of a Chromogenic Substrate Method for Photometric Determination of Prothrombin Time
866
Santoso, S; Kiefel, V; Mueller-Eckhardt, C: Redistribution of Platelet Glycoproteins Induced by Allo- and Autoantibodies
872
Jørgensen, Maja; Philips, Malou; Thorsen, Sixtus; Selmer, Johan; Zeuthen, Jesper: Plasminogen Activator Inhibitor-1 Is the Primary Inhibitor of Tissue-Type Plasminogen Activator in Pregnancy Plasma
879
Sié, P; Aillaud, M F; Prost, D de; Droullé, C; Forestier, F; Guedj, P; Juhan-Vague, I; Polack, B; Potron, G; Roncato, M; Roussi, J; Sampol, J; Aiach, M: Measurement of Low Molecular Weight Heparin Ex Vivo Activities in Clinical Laboratories Using Various Anti-Xa Assays: Interlaboratory Variability and Requirement for an Agreed Low Molecular Weight Heparin Standard
884
Lyon, Sandra G; Lasser, Elliott C; Stein, Rosalyn: Modification of an Amidolytic Heparin Assay to Express Protein-Bound Heparin and to Correct for the Effect of Antithrombin III Concentration
888
Wolf, M; Boyer-Neumann, C; Meyer, D; Tripodi, A; Mannucci, P M; Larrieu, M J: Purification and Further Characterization of Antithrombin III Milano: Lack of Reactivity with Thrombin
893
Bergqvist, David; Nilsson, Bodil: The Influence of Low Molecular Weight Heparin in Combination with Dihydroergotamine on Experimental Thrombosis and Haemostasis
896
Ghirardini, A; Mariani, G; lacopino, G; Tirindelli, M C; Solinas, S; Moretti, T: Concentrated DDAVP: Further Improvement in the Management of Mild Factor VIII Deficiencies
899
Bauman, Joan E; Joachim Reimers, H; Heinrich Joist, J: Deaggregation of In Vitro-Degranulated Human Platelets: Irreversibility of Aggregation May Be Agonist-Specific Rather Than Related to Secretion Per Se
905
Palareti, G; Coccheri, S; Poggi, M; Bonetti, M; Cervi, V; Mazzuca, A; Savoia, M; Veri, L; Fiori, F; Gaspari, G; Palareti, A; The Bologna oral anticoagulant control study group: Oral Anticoagulant Therapy Control: Evidence that INR Expression Improves the Inter-Laboratory Comparability of Results - The Bologna Oral Anticoagulant Control Exercise
911
Parker, R I; Shafer, Brenda C; Gralnick, H R: Platelet Density-Dependent Partition of Platelet- von Willebrand Factor Between Alpha Granule and Non-Alpha Granule Pools
915
Jandrot-Perrus, Martine; Guillin, Marie-Claude; Nurden, Alan T: Human Gamma-Thrombin: Lack of Correlation Between a Platelet Functional Response and Glycoprotein V Hydrolysis
921
Seifried, E; Tanswell, P: Comparison of Specific Antibody, D-Phe-Pro-Arg-CH2Cl and Aprotinin for Prevention of In Vitro Effects of Recombinant Tissue-Type Plasminogen Activator on Haemostasis Parameters
927
de Chaffoy de Courcelles, D; Roevens, P; Verheyen, F; Van Belle, H; De Clerck, F: The Effect of the Intracellular Calcium Chelator Quin-2 on the Platelet Phosphoinositide Metabolism, Protein Phosphorylation and Morphology
932
Palm, M; Mattsson, Ch: Pharmacokinetics of Heparin and Low Molecular Weight Heparin Fragment (Fragmin®) in Rabbits with Impaired Renal or Metabolic Clearance
936
Miles, Lindsey A; Plow, Edward F: Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells
943
Collen, D; Stassen, J M; De Cock, F: Synergistic Effect on Thrombolysis of Sequential Infusion of Tissue-Type Plasminogen Activator (t-PA) Single-Chain Urokinase-Type Plasminogen Activator (scu-PA) and Urokinase in the Rabbit Jugular Vein Thrombosis Model
947
Stassen, J M; Juhan-Vague, I; Alessi, M C; De Cock, F; Collen, D: Potentiation by Heparin Fragments of Thrombolysis Induced with Human Tissue-Type Plasminogen Activator or Human Single-Chain Urokinase-Type Plasminogen Activator